These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21506634)

  • 1. The 'perfect' adjuvant, a stronger voice.
    Glenn GM
    Expert Rev Vaccines; 2011 Apr; 10(4):399-400. PubMed ID: 21506634
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvants: no longer a 'dirty little secret', but essential key players in vaccines of the future.
    Arakawa T
    Expert Rev Vaccines; 2011 Jan; 10(1):1-5. PubMed ID: 21162613
    [No Abstract]   [Full Text] [Related]  

  • 3. IFN-α as a vaccine adjuvant: recent insights into the mechanisms and perspectives for its clinical use.
    Rizza P; Capone I; Moretti F; Proietti E; Belardelli F
    Expert Rev Vaccines; 2011 Apr; 10(4):487-98. PubMed ID: 21506646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances and challenges in mucosal adjuvant technology.
    Newsted D; Fallahi F; Golshani A; Azizi A
    Vaccine; 2015 May; 33(21):2399-405. PubMed ID: 25865473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine adjuvants: is the pipeline clogged?
    Leitner WW
    Immunotherapy; 2012 Jun; 4(6):565-7. PubMed ID: 22788122
    [No Abstract]   [Full Text] [Related]  

  • 6. TLR-7 and -8 agonists as vaccine adjuvants.
    Tomai MA; Vasilakos JP
    Expert Rev Vaccines; 2011 Apr; 10(4):405-7. PubMed ID: 21506636
    [No Abstract]   [Full Text] [Related]  

  • 7. New developments in nanoparticle-based vaccination.
    Riedmann EM
    Hum Vaccin Immunother; 2013 Dec; 9(12):2502. PubMed ID: 24716209
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines and adjuvants--special issue.
    Robinson K; Oyston P
    J Med Microbiol; 2012 Jul; 61(Pt 7):887-888. PubMed ID: 22538995
    [No Abstract]   [Full Text] [Related]  

  • 9. When an aluminium adjuvant is not an aluminium adjuvant used in human vaccination programmes.
    Exley C
    Vaccine; 2012 Mar; 30(12):2042. PubMed ID: 22041301
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccine adjuvants: a priority for vaccine research.
    Harandi AM; Medaglini D; Shattock RJ;
    Vaccine; 2010 Mar; 28(12):2363-6. PubMed ID: 20064476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New adjuvants for human vaccines.
    Mbow ML; De Gregorio E; Valiante NM; Rappuoli R
    Curr Opin Immunol; 2010 Jun; 22(3):411-6. PubMed ID: 20466528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The path to a successful vaccine adjuvant--'the long and winding road'.
    O'Hagan DT; De Gregorio E
    Drug Discov Today; 2009 Jun; 14(11-12):541-51. PubMed ID: 19508916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter from the editor.
    Ellis R; Riedmann EM
    Hum Vaccin Immunother; 2014; 10(4):813-4. PubMed ID: 24784356
    [No Abstract]   [Full Text] [Related]  

  • 14. ISCOMATRIX adjuvant for prophylactic and therapeutic vaccines.
    Drane D; Gittleson C; Boyle J; Maraskovsky E
    Expert Rev Vaccines; 2007 Oct; 6(5):761-72. PubMed ID: 17931156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine adjuvants: scientific challenges and strategic initiatives.
    Harandi AM; Davies G; Olesen OF
    Expert Rev Vaccines; 2009 Mar; 8(3):293-8. PubMed ID: 19249971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine adjuvant safety: the elephant in the room.
    Petrovsky N
    Expert Rev Vaccines; 2013 Jul; 12(7):715-7. PubMed ID: 23885815
    [No Abstract]   [Full Text] [Related]  

  • 17. Innate immunity and new adjuvants.
    Mutwiri G; Gerdts V; Lopez M; Babiuk LA
    Rev Sci Tech; 2007 Apr; 26(1):147-56. PubMed ID: 17633299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-33 isoforms: their future as vaccine adjuvants?
    Villarreal DO; Weiner DB
    Expert Rev Vaccines; 2015 Apr; 14(4):489-92. PubMed ID: 25656504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine and immunotherapy.
    Borchard G
    Expert Rev Vaccines; 2010 Nov; 9(11):1245-6. PubMed ID: 21087103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.